Galderma announces public take-over offer for Q-Med
The specialty dermatology firm Galderma, a joint venture of Nestlé and L’Oreal, has announced a public take-over offer to the shareholders of Q-Med. The SEK 6.7 billion bid was announced on December 13, 2010.
Q-Med is a medical device company that develops, manufactures, markets and sells high quality medical implants for aesthetic and medical use. Sales are made through the company’s own subsidiaries or distributors in over 70 countries and Q-Med has about 650 co-workers. The Q-Med share is listed on NASDAQ OMX Stockholm.
Q-Med is advised by Mannheimer Swartling on the offer. The firm’s team is led by Eva Hägg and Patrik Marcelius, primarily assisted by Emil Boström and Jenny Keisu. Stefan Perván Lindeborg and Jens Agö from the firm’s Brussels office are advising on anti-trust matters.